Sameer Gafoor, MD
Interventional Cardiology · Seattle, WANPI 1003933987
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (32.4%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Abbott at 50.4% of the total. 2025 is the largest year on record at $34,963, more than ten times the $1,263 reported in 2019. Among interventional cardiology clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 299 payments — averaging $266.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$40K
- Edwards Lifesciences$16K
- Inari Medical, Inc.$11K
- Boston Scientific$9K
- Biosense Webster, Inc.$1K
- Medtronic$1K
- plus $1K from 8 others
Across 335 payments — averaging $5708.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Edwards Lifesciences$1.2M
- Abbott$565K
- Medtronic$71K
- Boston Scientific$46K
- Biosense Webster, Inc.$17K
What the payments were for
- Consulting fees$20,00025%
- Speaking & faculty fees$15,50019%
- Grants$950%
- Travel & lodging$25,79532%
- Food & beverage$17,89722%
- Other$2820%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 111 | $40,107 |
| Edwards Lifesciences | 60 | $15,972 |
| Inari Medical, Inc. | 21 | $10,584 |
| Boston Scientific | 71 | $9,291 |
| Biosense Webster, Inc. | 5 | $1,240 |
| Medtronic(2 entities) | 13 | $1,040 |
| Stryker | 10 | $410 |
| Angiodynamics, Inc. | 1 | $254 |
| Atricure, Inc. | 2 | $156 |
| Abiomed | 1 | $147 |
| Philips North America LLC | 1 | $128 |
| E.r. Squibb & Sons, L.L.C. | 1 | $123 |
| Siemens Medical Solutions USA, Inc. | 1 | $94 |
| Novo Nordisk | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MitraClip$20,893
- TRICLIP$13,037
- FLOWTRIEVER CATHETER, S$10,266
- CT THROMBECTOMY SYSTEM KIT$10,266
- Watchman$3,233
- Edwards SAPIEN 3 Transcatheter Heart Valve$3,228
- PASCAL$2,610
- WATCHMAN Access System$2,437
- NAVITOR$2,087
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$1,875
- Thermocool SF$1,240
- SAPIEN 3 Ultra RESILIA$742
- CoreValve Evolut$681
- EVOQUE$626
- GENERAL - THERAPIES$308
- PORTICO$282
- ABSOLUTE PRO$272
- AlphaVac$254
- AMPLATZER AMULET$200
- Impella$147
How this compares
$79,569 in reported general payments places this provider in the 90th percentile of 125 interventional cardiology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 52 | $48,036 |
| FarxigaDapagliflozin Propanediol | 26 | $32,264 |
| EliquisApixaban | 13 | $16,189 |
| EntrestoSacubitril/Valsartan | 14 | $12,535 |
| ClopidogrelClopidogrel Bisulfate | 43 | $856 |
| Atorvastatin Calcium | 25 | $686 |
| Metoprolol Succinate | 35 | $627 |
| Bumetanide | 18 | $599 |
| Spironolactone | 70 | $465 |
| Losartan Potassium | 25 | $340 |
| Furosemide | 36 | $310 |
| Mupirocin | 25 | $214 |
| Lisinopril | 13 | $154 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 22 | $133 |
| Metoprolol Tartrate | 18 | $123 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Seattle
- William LombardiSeattle$902K
- Kathleen KearneySeattle$448K
- Danny DvirSeattle$374K
- James McCabeSeattle$289K
- Christopher BrownSeattle$266K
- Lorenzo AzzaliniSeattle$233K
- Sidakpal PanaichSeattle$214K
- Christine ChungSeattle$210K
- Ravi HiraSeattle$64K
- Ming ZhangSeattle$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.